EverQuote, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 9 fiscal years, taken from the XBRL data EverQuote, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2018	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	126	163	249	347	419	404	288	500	693
Cost of revenue	7.75	11.7	15.9	21.4	23.9	24	22.5	20.9	19.4
Gross profit	118	152	233	326	395	380	265	479	673
Research and development	9.19	14.2	20.2	29.7	35.7	31.7	27.6	29.6	31.5
Selling and marketing	109	141	203	285	355	349	240	388	541
General and administrative	4.52	10.7	16.8	20.4	24.7	28.1	26.3	30.3	34.1
Operating income	-4.69	-13.9	-8.05	-11.7	-21.9	-24.8	-52	31.8	58.3
Interest expense	0.38	0.2
Interest income		0.32		0.19	0.04	0.35	1.25	2.08	3.57
Other non-operating income	-0.38	0.12	0.93	0.48	-0.02	0.37	1.27	2.26	3.49
Pre-tax income			-7.12	-11.2	-21.9	-24.4	-50.7	34	61.8
Income tax	0	0	0	0	-2.51		0.58	1.84	-37.5
Net income	-5.07	-13.8	-7.12	-11.2	-19.4	-24.4	-51.3	32.2	99.3
EBITDA	-3.33	-12.6	-5.86	-8.33	-16.9	-18.9	-45.8	37.4	62.1
EPS, basic	-2.18	-3.03	-0.28	-0.41	-0.67	-0.77	-1.54	0.92	2.75
EPS, diluted	-2.18	-3.03	-0.28	-0.41	-0.67	-0.77	-1.54	0.88	2.63
Shares, basic (weighted)	8.77	16.9	0.03	0.03	0.03	0.03	33.4	35	36.1
Shares, diluted (weighted)	8.77	16.9	0.03	0.03	0.03	0.03	33.4	36.6	37.8

Balance sheet

	FY2018	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	2.36	41.6	46.1	42.9	34.9	30.8	38	102	171
Receivables	14.7	17.5	32.2	46.1	35.7	29.6	21.2	61.3	75.1
Other current assets	0.59	1.46	7.07	8.45	4.9	7.01	5.76	5.31	9.76
Total current assets	17.7	60.6	85.3	97.4	84.7	81	69.2	172	256
Property, plant and equipment	2.13	4.48	5.2	6.17	5.8	6.46	5.72	6.18	7.88
Lease right-of-use assets				9.62	7.29	5.77	1.62	3.41	2.36
Goodwill				9.79	21.5	21.5	21.5	21.5	21.5
Intangible assets				3.37	10.2	7.96	5.19	3.25	0
Other non-current assets	0.74	0.72	0.69	2.7	0.68	0.45	0.03	0.32	0.18
Total assets	20.5	65.7	91.2	129	144	157	111	211	327
Accounts payable	11.9	16.8	23.7	33	29.6	30.7	17.2	60	76.9
Accrued liabilities	0.43	1.37	2.39	4.11	4.12	4.25	5.19	4.8	4.57
Deferred revenue	0.99	1.44	1.5	1.87	2.1	1.87	1.87	1.77	1.66
Short-term debt	0.36
Total current liabilities	15	21.4	38.4	46.8	47.4	45.4	29.9	72.6	87.2
Long-term debt	4.25
Lease liabilities				8.09	5.53	3.5	0.07	2.51	1.37
Other non-current liabilities			1.06	3.13	5.55	0.13	0
Total liabilities	20.1	22.6	39.5	58.1	58.5	49	30	75.2	88.9
Total debt	4.61
Paid-in capital	0.77	143	159	189	223	270	294	317	320
Retained earnings	-51.3	-99.9	-107	-118	-138	-162	-213	-181	-81.9
Other comprehensive income				-0.01	0.01	-0.01	0.03	0	0.13
Shareholders' equity	-50.5	43.2	51.8	71	85.1	107	80.9	135	238
Total equity	-50.5	43.2	51.8	71	85.1	107	80.9	135	238
Total liabilities and equity	20.5	65.7	91.2	129	144	157	111	211	327

Cash flow statement

	FY2018	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-5.07	-13.8	-7.12	-11.2	-19.4	-24.4	-51.3	32.2	99.3
Depreciation and amortization	1.36	1.34	2.19	3.35	5.07	5.85	6.2	5.67	3.81
Stock-based compensation	1.86	7.12	12.7	24.2	30	29	24.1	20.6	24.3
Deferred income tax					-2.51				-38.4
Change in receivables	-2.48	-2.77	-15.2	-14	10.5	5.36	8.22	-40.2	-13.8
Change in payables	1.55	4.93	6.84	9.3	-3.97	1.12	-13.4	42.7	16.9
Cash from operations	-1.67	-1.9	4.41	10.7	7.19	-15.8	-2.83	66.6	95.4
Capital expenditures	-1.19	-3.67	-2.98	-3.82	-2.86	-4.29	-3.84	-4.11	-5.06
Acquisitions				-14.9	-16
Cash from investing	-1.19	-3.67	-2.98	-18.8	-18.8	-4.29	9.35	-4.11	-5.06
Stock issued	1.55	0.86	2.98	4.91	3.62	0.94	0.98	3.55	3.93
Share buybacks	-9.23								-21
Cash from financing	-7.18	44.8	2.98	4.91	3.62	15.8	0.58	1.71	-21.1
Exchange rate effect				-0.01	-0.01
Net change in cash	-10	39.3	4.42	-3.18	-8.02	-4.27	7.12	64.2	69.3
Free cash flow	-2.86	-5.57	1.44	6.85	4.33	-20.1	-6.67	62.5	90.3
Interest paid	0.35	0.21
Income taxes paid						0.18	0.59	2.34	3.15

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $18.64 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	97.6%	Gross profit / revenue.
Operating margin	11.0%	Operating income / revenue.
EBITDA margin	11.5%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	11.5%	Pre-tax income / revenue.
Net margin	15.2%	Net income / revenue.
FCF margin	12.6%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	13.3%	Cash from operations / revenue.
Effective tax rate	-31.6%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	44.6%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	33.6%	Net income / average total assets.
Return on invested capital (ROIC)	101.8%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	4.5%	Research and development expense / revenue.
Stock-based pay / revenue	3.1%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.7%	Capital expenditures / revenue.
D&A / revenue	0.5%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	38.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	19.7%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	14.8%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	40.5%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	21.0%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	15.6%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	83.7%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	66.1%	EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y	208.7%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	198.9%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	43.3%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 5y	55.0%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	44.6%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	67.5%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	75.8%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	30.3%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	27.4%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	55.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	27.8%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	20.4%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	3.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	961.0%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	324.7%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	3.33x	Current assets / current liabilities.
Quick ratio	3.22x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	2.31x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	24.7%	Total liabilities / total assets.
Working capital	$194.3M	Current assets - current liabilities.
Goodwill and intangibles / assets	6.3%	(Goodwill + intangible assets) / total assets.
Tangible book value	$235.3M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	2.21x	Revenue / average total assets.
Fixed asset turnover	82.1x	Revenue / average property, plant and equipment.
Receivables turnover	9.93x	Revenue / average receivables.
Days sales outstanding	37 days	365 x average receivables / revenue.
Days payables	1,443 days	365 x average accounts payable / cost of revenue.
FCF conversion	83.1%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	5.5%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$3.17	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$20.89	Revenue / diluted weighted shares.
FCF per share	$2.63	Free cash flow / diluted weighted shares.
Operating cash flow per share	$2.78	Cash from operations / diluted weighted shares.
Book value per share	$7.10	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$6.51	Tangible book value / shares outstanding.
Cash per share	$5.32	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$656.9M	Share price x shares outstanding.
Enterprise value	$464.6M	Market cap + total debt - cash - short-term investments.
P/E	5.74x	Market cap / net income. Only when net income is positive.
P/S	0.87x	Market cap / revenue.
P/B	2.56x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	2.79x	Market cap / tangible book value, when positive.
P/FCF	6.90x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	6.52x	Market cap / cash from operations, when positive.
EV/Sales	0.62x	Enterprise value / revenue.
EV/EBIT	5.59x	Enterprise value / operating income, when both are positive.
EV/EBITDA	5.37x	Enterprise value / EBITDA, when both are positive.
EV/FCF	4.88x	Enterprise value / free cash flow, when both are positive.
FCF yield	14.5%	Free cash flow / market cap.
Earnings yield	17.4%	Net income / market cap (the inverse of P/E).

What was EverQuote, Inc.'s revenue in fiscal 2025?

EverQuote, Inc. reported revenue of $692.5M for fiscal 2025, 38.5% higher than the year before.

Was EverQuote, Inc. profitable in fiscal 2025?

Yes. Net income was $99.3M, a net margin of 14.3%.

How much free cash flow did EverQuote, Inc. generate in fiscal 2025?

Cash from operations of $95.4M minus capital expenditures of $5.1M left free cash flow of $90.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to EverQuote, Inc.